Bixiye
P3-18 New Drug-Related PA Criteria: Inhaled Antibiotics Duplicate Therapy
Taariikhda uu dhaqangalayo Barnaamijka: Jan 24, 2018
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2881 - 2890 ee natiijooyinka 3607
Bixiye
P43-17 New Drug-Related Prior Authorization Criteria for Symbicort
Taariikhda barnaamijka Dhaqangalayso Agosto 07, 2017
Bixiye
P51-18 Lab Management Program CPT Code Update for Fully Insured Commercial Members - eviCore Healthcare Specialty Utilization Management (UM) Program
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2018
Bixiye
P52-17 New Drug-Related Prior Authorization with Quantity Limit Criteria: Parathyroid Hormone Analog for Osteoporosis
Taariikhda uu dhaqangalayo barnaamijka: Okt 03, 2017
Bixiye
P9-17 A New Drug, Ingrezza (valbenazine) Will Require Prior Authorization
Taariikhda uu dhaqangalayo Barnaamijka: Mar 21, 2017
Bixiye
P48-17 EquiClaim to Perform Focused and Limited Hospital Bill Validation Services
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 19, 2017
Bixiye
P21-17 New Drug-Related Prior Authorization with Quantity Limit for Entresto
Taariikhda uu dhaqangalayo Barnaamijka: May 08, 2017
Bixiye
P45-17 New Drug-Related Prior Authorization and Quantity Limit Criteria: Concurrent Opioids with Buprenorphine
Taariikhda barnaamijka Dhaqangalayso Agosto 14, 2017
Bixiye
P13-17 Added Reimbursement Policy for General Coding: Total Parenteral Nutrition Billing
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 07, 2017